Get notified when AGL files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NYSE: AGL agilon health, inc. 8-K

agilon health names Tim O'Rourke CEO with equity tied to $50-$150 stock price targets

Filed April 27, 2026 · Period ending April 24, 2026 · ~1 min read

Key Changes

  • high

    Tim O'Rourke appointed CEO and President effective May 7, 2026, bringing healthcare leadership experience from Help at Home, Centene, and Humana. He also joins the Board as a Class III director.

  • high

    O'Rourke receives 200,000 performance stock units vesting in thirds when stock hits $50, $100, and $150 over 30 consecutive trading days within three years—signaling board confidence in major upside.

    Item 5.02: Employment Agreement verify on EDGAR →
  • medium

    Base compensation set at $850,000 salary plus 100% target bonus ($850,000) and $500,000 signing bonus, repayable if he leaves voluntarily or is terminated for cause within one year.

    Item 5.02: Compensation verify on EDGAR →

2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (TRV 10-Q) is open in full — no account needed.

Partner

Trade AGL commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?

Source-verified from EDGAR · Narrative written by AI · Jun 4, 2026 · How we verify